S. Winkler

In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.

J. Mellors, Y. Cheng, E. Tramontano, 1992, Molecular pharmacology.

A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).

J. Mellors, Y. Cheng, E. Tramontano, 1993, Molecular pharmacology.

Comparison of techniques for recovering murine cytomegalovirus from a macrophage-enriched subpopulation of mice

J. Booss, S. Winkler, 1980, Journal of clinical microbiology.

Comparison ofTechniques forRecovering Murine Cytomegalovirus froma Macrophage-Enriched Subpopulation ofMice

J. Booss, S. Winkler, 1980 .

Genetic determinants of lung virus titers and resistance to lethal Sendai virus pneumonia

D. Brownstein, S. Winkler, 2005, Archives of Virology.

Viremia and glial nodule encephalitis after experimental systemic cytomegalovirus infection.

J. Booss, B. Griffith, J. Kim, 1989, Laboratory investigation; a journal of technical methods and pathology.

Genetic resistance to lethal Sendai virus pneumonia: virus replication and interferon production in C57BL/6J and DBA/2J mice.

D. Brownstein, S. Winkler, 1986, Laboratory animal science.

Mechanisms of injury to the central nervous system following experimental cytomegalovirus infection.

J. Booss, B. Griffith, J. Kim, 1990, American journal of otolaryngology.